No black box warning on record for Belsomra

As of the latest FDA labeling reviewed, Belsomra (SUVOREXANT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Belsomra medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS CNS Depressant Effects and Daytime Impairment: Risk of impaired alertness and motor coordination, including impaired driving; risk increases with dose; caution patients taking 20 mg against next-day driving and other activities requiring complete mental alertness ( 5.1 ). Worsening of Depression/Suicidal Ideation: Worsening of depression or suicidal thinking may occur. R

No black box warning on record for Belsomra

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS CNS Depressant Effects and Daytime Impairment: Risk of impaired alertness and motor coordination, including impaired driving; risk increases with dose; caution patients taking 20 mg against next-day driving and other activities requiring complete mental alertness ( 5.1 ). Worsening of Depression/Suicidal Ideation: Worsening of depression or suicidal thinking may occur. R

Belsomra Black Box Warning

No black box warning on record for Belsomra

Other warnings & precautions

Belsomra Black Box Warning

No black box warning on record for Belsomra

Other warnings & precautions